Kevin Grady is quoted in the article "Oxford, WellChoice Deal Would Raise Antitrust Concerns." WellChoice is in advanced talks to acquire Oxford through a stock swap, and the two companies are already "the biggest players in the metropolitan New York city area." Mr. Grady said there would "be a concern among physicians if there is any attempt to have an acquisition in the same state with a large percentage of covered lives."